Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehmet K Samur

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Blood Advances|November 8, 2018
Insights into the genomic landscape of MYD88 wild-type Waldenström macroglobulinemiaZachary R Hunter, Lian Xu, Nickolas Tsakmaklis, et al.
Blood|September 20, 2014
Differential and limited expression of mutant alleles in multiple myelomaNaim U Rashid, Adam S Sperling, Niccolo Bolli, et al.
Blood|April 29, 2025
The mitochondrial protease ClpP is a metabolic vulnerability and an immunogenic trigger against multiple myelomaTommaso Perini, Paola Zordan, Rossella Del Pizzo, et al.
Haematologica|October 21, 2021
Apoptosis reprogramming triggered by splicing inhibitors sensitizes multiple myeloma cells to Venetoclax treatmentDebora Soncini, Claudia Martinuzzi, Pamela Becherini, et al.
Blood|January 19, 2017
Functional role and therapeutic targeting of p21-activated kinase 4 in multiple myelomaMariateresa Fulciniti, Joaquin Martinez-Lopez, William Senapedis, et al.
Blood|March 19, 2020
YWHAE/14-3-3ε expression impacts the protein load, contributing to proteasome inhibitor sensitivity in multiple myelomaYan Xu, Mariateresa Fulciniti, Mehmet K Samur, et al.
Blood|May 22, 2025
CRISPR-Cas13d functional transcriptomics reveals widespread isoform-selective cancer dependencies on lncRNAsEugenio Morelli, Anil Aktas-Samur, Domenico Maisano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2015
Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple MyelomaGüllü Görgün, Mehmet K Samur, Kristen B Cowens, et al.
Blood Cancer Discovery|October 17, 2025
ID2 Suppresses Multiple Myeloma Cell Proliferation by Repressing the Activity of the Transcription Factor TCF3Mariateresa Fulciniti, Yao Yao, Tommaso Perini, et al.
Blood|March 22, 2021
miR-15a/16-1 deletion in activated B cells promotes plasma cell and mature B-cell neoplasmsTomasz Sewastianik, Juerg R Straubhaar, Jian-Jun Zhao, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Blood Advances|November 8, 2018
Insights into the genomic landscape of MYD88 wild-type Waldenström macroglobulinemiaZachary R Hunter, Lian Xu, Nickolas Tsakmaklis, et al.
Blood|September 20, 2014
Differential and limited expression of mutant alleles in multiple myelomaNaim U Rashid, Adam S Sperling, Niccolo Bolli, et al.
Blood|April 29, 2025
The mitochondrial protease ClpP is a metabolic vulnerability and an immunogenic trigger against multiple myelomaTommaso Perini, Paola Zordan, Rossella Del Pizzo, et al.
Haematologica|October 21, 2021
Apoptosis reprogramming triggered by splicing inhibitors sensitizes multiple myeloma cells to Venetoclax treatmentDebora Soncini, Claudia Martinuzzi, Pamela Becherini, et al.
Blood|January 19, 2017
Functional role and therapeutic targeting of p21-activated kinase 4 in multiple myelomaMariateresa Fulciniti, Joaquin Martinez-Lopez, William Senapedis, et al.
Blood|March 19, 2020
YWHAE/14-3-3ε expression impacts the protein load, contributing to proteasome inhibitor sensitivity in multiple myelomaYan Xu, Mariateresa Fulciniti, Mehmet K Samur, et al.
Blood|May 22, 2025
CRISPR-Cas13d functional transcriptomics reveals widespread isoform-selective cancer dependencies on lncRNAsEugenio Morelli, Anil Aktas-Samur, Domenico Maisano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2015
Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple MyelomaGüllü Görgün, Mehmet K Samur, Kristen B Cowens, et al.
Blood Cancer Discovery|October 17, 2025
ID2 Suppresses Multiple Myeloma Cell Proliferation by Repressing the Activity of the Transcription Factor TCF3Mariateresa Fulciniti, Yao Yao, Tommaso Perini, et al.
Blood|March 22, 2021
miR-15a/16-1 deletion in activated B cells promotes plasma cell and mature B-cell neoplasmsTomasz Sewastianik, Juerg R Straubhaar, Jian-Jun Zhao, et al.
Pageof 5